Imaz, Arkaitz
Niubó, Jordi
Amara, Alieu
Khoo, Saye
Ferrer, Elena
Tiraboschi, Juan M
Acerete, Laura
Garcia, Benito
Vila, Antonia
Podzamczer, Daniel
Article History
Received: 2 January 2018
Revised: 14 February 2018
Accepted: 22 February 2018
First Online: 14 March 2018
Compliance with ethical standards
:
: A.I. has received financial compensation for lectures, consultancies, and educational activities, or research funding for from AbbVie, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme and ViiV Healthcare. J.N. has received financial compensation for lectures and research from Abbott Molecular. S.K. has received funding from Merck Gilead Sciences Jannsen and ViiV Healthcare for research and support of the HIV drug interactions website. J.M.T. has received financial compensation for lectures, consultancies, and educational activities, or research funding for from AbbVie, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme and ViiV Healthcare. E.F. has received honoraria for advisories and/or conferences from Viiv, BMS, Abbott, Gilead, Janssen and Merck. D.P. has received research grants and/or honoraria for advisories and/or conferences from Viiv, BMS, Abbott, Gilead, Janssen and Merck. A.A, L.A., B.G. and A.V. declare no conflicts of interest regarding this article.